| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.ATV.13.12.1822 |
| P698 | PubMed publication ID | 8241103 |
| P2093 | author name string | B E Sobel | |
| D J Schneider | |||
| T K Nordt | |||
| K J Klassen | |||
| P433 | issue | 12 | |
| P921 | main subject | plasminogen | Q107129060 |
| P304 | page(s) | 1822-1828 | |
| P577 | publication date | 1993-12-01 | |
| P1433 | published in | Arteriosclerosis and thrombosis : a journal of vascular biology | Q27709770 |
| P1476 | title | Augmentation of synthesis of plasminogen activator inhibitor type-1 in arterial endothelial cells by glucose and its implications for local fibrinolysis | |
| P478 | volume | 13 |
| Q36835905 | Association of Acute and Chronic Hyperglycemia With Acute Ischemic Stroke Outcomes Post-Thrombolysis: Findings From Get With The Guidelines-Stroke |
| Q41719625 | Blood glucose and platelet-dependent thrombosis in patients with coronary artery disease |
| Q50261674 | Burton Elias Sobel, MD: a conversation with the editor. Interview by William Clifford Roberts |
| Q24796861 | Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas |
| Q55331908 | Diabetes-associated dysregulated cytokines and cancer. |
| Q44104205 | Effect of glucose tolerance status on PAI-1 plasma levels in overweight and obese subjects |
| Q47972160 | Effect of insulin versus sulfonylurea therapy on cardiovascular risk factors and fibrinolysis in type II diabetes |
| Q92163028 | Effects of different diets used in diet-induced obesity models on insulin resistance and vascular dysfunction in C57BL/6 mice |
| Q52533093 | Effects of lipids and lipoproteins on thrombosis and rheology. |
| Q80505490 | Endothelial dysfunction in diabetes mellitus |
| Q36012867 | Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome |
| Q36197578 | Evaluation of Fibrinolytic Inhibitors: Alpha-2-Antiplasmin and Plasminogen Activator Inhibitor 1 in Patients with Obstructive Sleep Apnoea. |
| Q40406437 | Fibrinolysis and atherosclerosis |
| Q83000676 | Fibrinolysis and insulin sensitivity in imidapril and candesartan (FISIC study) recipients with hypertension |
| Q41111872 | GTSF-2: a new, versatile cell culture medium for diverse normal and transformed mammalian cells |
| Q28568001 | Glucose upregulates plasminogen activator inhibitor-1 gene expression in vascular smooth muscle cells |
| Q43833280 | Hyperglycemia induces PAI-1 gene expression in adipose tissue by activation of the hexosamine biosynthetic pathway |
| Q36415843 | Impaired fibrinolysis and risk for cardiovascular disease in the metabolic syndrome and type 2 diabetes |
| Q44510088 | PAI-1 polymorphisms modulate phenotypes associated with the metabolic syndrome in obese and diabetic Caucasian population |
| Q34384926 | Plasminogen activator inhibitor type-1 (part one): basic mechanisms, regulation, and role for thromboembolic disease |
| Q40520981 | TGFbeta1 is involved in high glucose-induced accumulation of pericellular chondroitin sulphate in human endothelial cells |
| Q34340559 | The role of fat cell derived peptides in age-related metabolic alterations |
| Q90796954 | Thrombolysis Outcomes in Patients with Diabetes and Previous Stroke: A Meta-Analysis |
Search more.